Cofoe Medical Technology Co Ltd
SZSE:301087
Income Statement
Earnings Waterfall
Cofoe Medical Technology Co Ltd
Revenue
|
2.8B
CNY
|
Cost of Revenue
|
-1.6B
CNY
|
Gross Profit
|
1.2B
CNY
|
Operating Expenses
|
-981.2m
CNY
|
Operating Income
|
188.8m
CNY
|
Other Expenses
|
32.1m
CNY
|
Net Income
|
221m
CNY
|
Income Statement
Cofoe Medical Technology Co Ltd
Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||
Revenue |
3 023
N/A
|
2 246
-26%
|
2 331
+4%
|
2 276
-2%
|
2 229
-2%
|
2 472
+11%
|
2 456
-1%
|
2 977
+21%
|
3 232
+9%
|
3 200
-1%
|
3 223
+1%
|
2 854
-11%
|
2 805
-2%
|
|
Gross Profit | ||||||||||||||
Cost of Revenue |
(1 650)
|
(1 228)
|
(1 249)
|
(1 296)
|
(1 302)
|
(1 525)
|
(1 569)
|
(1 839)
|
(1 872)
|
(1 848)
|
(1 832)
|
(1 670)
|
(1 635)
|
|
Gross Profit |
1 373
N/A
|
1 018
-26%
|
1 083
+6%
|
980
-10%
|
927
-5%
|
947
+2%
|
887
-6%
|
1 137
+28%
|
1 359
+19%
|
1 353
0%
|
1 391
+3%
|
1 184
-15%
|
1 170
-1%
|
|
Operating Income | ||||||||||||||
Operating Expenses |
(713)
|
(582)
|
(606)
|
(482)
|
(541)
|
(600)
|
(626)
|
(865)
|
(999)
|
(993)
|
(1 026)
|
(961)
|
(981)
|
|
Selling, General & Administrative |
(689)
|
(568)
|
(576)
|
(454)
|
(528)
|
(570)
|
(597)
|
(712)
|
(826)
|
(821)
|
(844)
|
(789)
|
(874)
|
|
Research & Development |
(56)
|
(57)
|
(65)
|
(67)
|
(80)
|
(91)
|
(95)
|
(110)
|
(127)
|
(127)
|
(127)
|
(104)
|
(107)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
(50)
|
0
|
0
|
0
|
(72)
|
0
|
0
|
0
|
(102)
|
0
|
|
Other Operating Expenses |
32
|
42
|
36
|
89
|
67
|
61
|
65
|
29
|
(45)
|
(46)
|
(55)
|
35
|
0
|
|
Operating Income |
660
N/A
|
436
-34%
|
477
+9%
|
497
+4%
|
386
-22%
|
346
-10%
|
261
-25%
|
273
+5%
|
360
+32%
|
360
0%
|
365
+2%
|
223
-39%
|
189
-15%
|
|
Pre-Tax Income | ||||||||||||||
Interest Income Expense |
4
|
3
|
1
|
13
|
23
|
57
|
73
|
97
|
100
|
82
|
83
|
63
|
63
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
1
|
3
|
(29)
|
7
|
8
|
8
|
8
|
5
|
|
Total Other Income |
(3)
|
(1)
|
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
(6)
|
(35)
|
(36)
|
(36)
|
(8)
|
(8)
|
|
Pre-Tax Income |
661
N/A
|
438
-34%
|
476
+9%
|
508
+7%
|
406
-20%
|
400
-2%
|
334
-16%
|
334
+0%
|
431
+29%
|
414
-4%
|
420
+2%
|
286
-32%
|
249
-13%
|
|
Net Income | ||||||||||||||
Tax Provision |
(106)
|
(71)
|
(79)
|
(79)
|
(54)
|
(54)
|
(40)
|
(32)
|
(48)
|
(44)
|
(45)
|
(33)
|
(28)
|
|
Income from Continuing Operations |
555
|
367
|
397
|
430
|
352
|
346
|
294
|
302
|
383
|
370
|
375
|
253
|
221
|
|
Income to Minority Interest |
(1)
|
(1)
|
(0)
|
(1)
|
(3)
|
(2)
|
(2)
|
(0)
|
3
|
1
|
1
|
1
|
0
|
|
Net Income (Common) |
462
N/A
|
274
-41%
|
304
+11%
|
429
+41%
|
349
-19%
|
343
-1%
|
292
-15%
|
302
+3%
|
386
+28%
|
370
-4%
|
376
+2%
|
254
-32%
|
221
-13%
|
|
EPS (Diluted) |
2.21
N/A
|
1.31
-41%
|
5.92
+352%
|
2.61
-56%
|
1.67
-36%
|
1.63
-2%
|
1.4
-14%
|
1.45
+4%
|
1.87
+29%
|
1.76
-6%
|
1.82
+3%
|
1.24
-32%
|
1.07
-14%
|